Pharmaceutical Market Access Act of 2005

S 3807, Enhancing Drug Safety and Innovation Act of 2006 HR 6257, Access to LIfe-Saving Medicine Act Drug Approval Issues, Drug Safety Issues, FDA Issues Clinical Trials Conflict of Interest, Follow-On Biologics, PDUFA IV Issues relating to generics, biotechnology and drug reimportation HR 700/S334 Pharmaceutical Market Access and Drug and Safety Act of 2005/S334 HR 328/S109 Pharmaceutical market Acces Act of 2005 S930 Food and Drug Administration Safety Act of 2005

Client expense: $730,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Legislation regarding pandemic vaccine production: H.R.3970, Bioterror Pandemic Preparedness Protection Act; H.R.4062, Pandemic Preparedness Response Act; H.R.4603, Pandemic Seasonal Influenza Act of 2005; S.1437, Bioterror Pandemic Preparedness Protection Act;S.1821, Pandemic Preparedness Response Act; S.1873, Biodefense Pandemic Vaccine Drug Development Act of 2005; S.1880, National Biodefense Pandemic Preparedness Act of 2005. Preserve Access to Affordable Drugs Act of 2005; S.873, Medicare Prescription drug Savings and Choice Act of 2005; S.930, Food and Drug Administration Safety Act of 2005. Legislation controlling access to precursor chemicals for meth production and/or combating meth: H.R.1056, Methamphetamine Precursor Control Act of 2005; H.R.13, Clean, Learn, Educate, Abolish, Neutralize, and Undermine Production (CLEAN-UP) of Methamphetamine Act; H.R.1350, Methamphetamine Blister Pack Loophole Elimination Act of 2005; H.R.2335, Meth-Endangered Children Protection Act of 2005; H.R.313, Exile Meth Act; H.R.314, Combat Meth Act of 2005; H.R.3199, Patient Act H.R.1572, Preserving Access to Affordable Drugs Act of 2005; H.R.1626, Medicare Prescription Drug Improvement Act; H.R.1669, Pharmacy Benefit Manager Transparency Act of 2005; H.R.328, Pharmaceutical Market Access Act of 2005; H.R.417, Medical Innovation Prize Act of 2005; H.R.4660, Requiring Emergency Pharmaceutical Access for Individual Relief (REPAIR) Act of 2006; H.R.4663, Authorize the Secretary of HHS to Reimburse States for Expenditures Associated with the Implementation of the Medicare Prescription Drug Benefit for Dual Eligible Individuals; H.R.4665, Amend Title XIX of the Social Security Act to Provide for an Offset from the Medicaid Clawback for State Emergency Prescription Drug Expenditures for Medicare Dual-Eligible Individuals; H.R.4675, Medicare State Reimbursement Act of 2006; H.R.4685, Medicare Prescription Drug Emergency Guarantee Act of 2006; H.R.4715, Amend Title XVIII of the Social Secruity Act to Estend the 2006 Annual Coordinated Election Period for Medicare Prescription Drug Plans through August 15, 2006; H.R.4719, Patients Before Profits Act of 2006; H.R.4721, Require Secretary of HHS To Provide Federal Medicaid for State Costs Associated with Ensuring Access to Prescription Drug Benefits to Part D Eligible Individuals; H.R.700, Pharmaceutical Market Access and Drug Safety Act of 2005; H.R.752, Medicare Prescription Drug Savings and Choice Act of 2005; H.R.870, Pharmaceutical research and Manufacturers Accountability Act of 2005, PhRMA Act of 2005; S.109, Pharmaceutical Market Access Act of 2005; S.1128, Pharmaceutical Advertising and Prudent Purchasing Act; S.334, Pharmaceutical Market Access and Drug Safety Act of 2005; S.354, HEALTH Act of 2005, Health Efficient, Accessible, Low-Cost, timely Healthcare Act of 2005; S.764, Preserve Access to Affordable Drugs Act of 2005; S.873, Medicare Prescription drug Savings and Choice Act of 2005; S.930, Food and Drug Administration Safety Act of 2005. Methamphetamine Precursor Control Act of 2005; H.R.13, Clean, Learn, Educate, Abolish, Neutralize, and Undermine Production (CLEAN-UP) of Methamphetamine Act; H.R.1350, Methamphetamine Blister Pack Loophole Elimination Act of 2005; H.R.152, Preserving Access to Affordable Drugs Act of 2005; H.R.1572, Preserving Access to Affordable Drugs Act of 2005; H.R.1626, Medicare Prescription Drug Improvement Act; H.R.1669, Pharmacy Benefit Manager Transparency Act of 2005; H.R.2335, Meth-Endangered Children Protection Act of 2005; H.R.313, Exile Meth Act; H.R.314, Combat Meth Act of 2005; H.R.3199, Patient Act Reauthorization; H.R.328, Pharmaceutical Market Access Act of 2005; H.R.3324, Arrest Methamphetamine Act of 2005; H.R.3889, The Methamphetamine Elimination Act; H.R.3970, Bioterror Pandemic Preparedness Protection Act; H.R.4062, Pandemic Preparedness Response Act; H.R.4603, Pandemic Seasonal Influenza Act of 2005; H.R.4660, Requiring Emergency Pharmaceutical Access for Individual Relief (REPAIR) Act of 2006; H.R.4663, Authorize the Secretary of HHS to Reimburse States for Expenditures Associated with the Implementation of the Medicare Prescription Drug Benefit for Dual Eligible Individuals; H.R.4665, Amend Title XIX of the Social Security Act to Provide for an Offset from the Medicaid Clawback for State Emergency Prescription Drug Expenditures for Medicare Dual-Eligible Individuals; H.R.4675, Medicare State Reimbursement Act of 2006; H.R.4685, Medicare Prescription Drug Emergency Guarantee Act of 2006; H.R.4715, Amend Title XVIII of the Social Secruity Act to Estend the 2006 Annual Coordinated Election Period for Medicare Prescription Drug Plans through August 15, 2006; H.R.4719, Patients Before Profits Act of 2006; H.R.4721, Require Secretary of HHS To Provide Federal Medicaid for State Costs Associated with Ensuring Access to Prescription Drug Benefits to Part D Eligible Individuals; H.R.700, Pharmaceutical Market Access and Drug Safety Act of 2005; H.R.417, Medical Innovation Prize Act of 2005; H.R.752, Medicare Prescription Drug Savings and Choice Act of 2005; H.R.798, Methamphetamine Remediation Act of 2005; H.R.870, Pharmaceutical research and Manufacturers Accountability Act of 2005, PhRMA Act of 2005; S.103, Combat Meth Act of 2005; S.109, Pharmaceutical Market Access Act of 2005; S.1128, Pharmaceutical Advertising and Prudent Purchasing Act; S.1361, A bill to amend the Controlled Substances Act to treat drug offenses involving crystal meth similarly to drug offenses involving crack cocaine; S.1437, Bioterror Pandemic Preparedness Protection Act; S.1821, Pandemic Preparedness Response Act; S.1873, Biodefense Pandemic Vaccine Drug Development Act of 2005; S.1880, National Biodefense Pandemic Preparedness Act of 2005; S.334, Pharmaceutical Market Access and Drug Safety Act of 2005; S.354, HEALTH Act of 2005, Health Efficient, Accessible, Low-Cost, timely Healthcare Act of 2005; S.764, H.CON.RES.75, Expressing the sense of the congress that the illegal importation of prescription drugs severely undermines the regulatory protections afforded to the United States consumers, and for other purposes; H.R.1056,

Client expense: $860,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues HR 870, The PhRMA Research and Manufacturers Accountability (PhRMA) Act, drug safety S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues S 470, The Fair Access to Clinical Trials ("FACT") Act of 2005, drug safety S 930, Food and Drug Administration Safety Act of 2005, drug safety HR 5156, Counterfeiting Drug Prevention Act, pharmaceutical counterfeiting HR 2090, The Food and Drug Administration Improvement Act of 2005, drug safety HR 3196, The Fair Access to Clinical Trials ("FACT") Act of 2005, drug safety HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation, drug safety

Client expense: $6,000,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical countefeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues HR 3010, Department of Labor, Health and Human Service, and Education, and Related Agencies Appropriations Act, 2006, access to prescription drugs HR 3971, Social Services Emergency Relief and Recovery Act of 2005, access to prescription drugs HR 5993, Authorized Generics Prohibition, authorized generics S 3695, Authorized Generics Prohibition, authorized generics HR 4157, Better Health Information System Act, health information technology HR 4642, Wired for Health Act, health information technology S 1418, Wired for Health Act, health information technology S 2300, Lower Priced Drug Act, generic drug access HR 5005, Ryan White Care Act, reauthorization S 2339, Ryan White Care Act, reauthorization HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues

Client expense: $6,000,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importaion, patent issues

Client expense: $6,000,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues HR 3010, Department of Labor, Health and Human Service, and Education, and Related Agencies Appropriations Act, 2006, access to prescription drugs HR 3971, Social Services Emergency Relief and Recovery Act of 2005, access to prescription drugs HR 5993, Authorized Generics Prohibition, authorized generics S 3695, Authorized Generics Prohibition, authorized generics HR 4157, Better Health Information System Act, health information technology S 2300, Lower PRICED Drug Act, generic drug access, legislation on pediatric exclusivity, citizens petitions HR 6134, Ryan White Care Act, reauthorization S 2339, Ryan White Care Act, reauthorization HR 5975, Prescription Drug Comparative Effectiveness Act, drug prescriptions S 1355, Better Healthcare Through Information Technology Act, health information technology HR 6289, Personalized Health Information Act of 2006, health information technology HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues

Client expense: $5,800,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, imporation, patent issues S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues S 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To Amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To amend title 35, United States Code, to conform certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 3818, Patent Reform Act of 2006 S 3175, Life-Saving Medicines Export Act of 2006, compulsory licensing S 3834, Online Pharmacy Consumer Protection Act of 2006, prescription drugs S 1903, Generic Prescription Drug Fairness Act of 2005, authorized generics and rebates

Client expense: $5,800,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues HR 870, The PhRMA Research and Manufacturers Accountability (PhRMA) Act, drug safety S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues S 470, The Fair Access to Clinical Trials ("FACT") Act of 2005, drug safety S 930, Food and Drug Administration Safety Act of 2005, drug safety HR 5156, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting S 3834, Online Pharmacy Consumer Protection Act of 2006, drug safety HR 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 4157, Better Health Information System Act, health information technology HR 5975, Prescription Drug Effectiveness Act, drug prescriptions S 2699, Neglected Diseases Elimination Act, promote R&D HR 2090, The Food and Drug Administration Improvement Act of 2005, drug safety HR 3196, The Fair Access to Clinical Trials ("RACT") Act of 2005, drug safety HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation, drug safety

Client expense: $5,800,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

e) S. 109, "Pharmaceutical Market Access Act of 2005". f) S. 334, "Pharmaceutical Market Access & Drug Safety Act of 2005". g) Issues related to clinical trial data bank. h) S. 470, H.R. 3196, "Fair Access to Clinical Trials Act". i) H.R. 6257, "Access to Life-Saving Medicines Act". a) Issues related to Drug Safety, Generic Biologics & Drug Approvals, FDA User Fees. b) S.930, "Food & Drug Administration Act of 2005". c) H.R. 2090, "Food & Drug Administration Improvement Act of 2005". d) H.R. 700, "Pharmaceutical Market Access & Drug Safety Act of 2005" - Importation.

Client expense: $1,231,846 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

H.R. 700/S.334 - Pharmaceutical Market Access & Drug Safety Act of 2005 Legislation on issues pertaining to proposed Medical Prescription drug benefits Legislation on issues regarding FDA regulation of prescription drugs Congressional oversight on drug safety S. 109/H.R. 328 - Pharmaceutical Market Access Act of 2005

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S 334, Pharmaceutical Market Access and Drug Safety Act of 2005. S 471, Stem Cell Research Enhancement Act of 2005. Biologics, generics, importation issues. FDA issues. Drug safety issues. Clinical trial issues. Conflict of interest, follow on biologics, steroid abuse, stem cells. PDUFA. HR 2090, Food and Drug Administration Improvement Act of 2005. S 2766, National Defense Authorization Act for Fiscal Year 2007; Drug pricing issues. HR 328, Pharmaceutical Market Access Act of 2005. HR 6143, Ryan White HIV/AIDS Treatment Modernization Act of 2006. S 3807, Bill to amend the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act to improve drug safety and oversight, and for other purposes. S 4016 & HR 6257, Bill to amend the Public Health Service Act to provide for the licensing of comparable biological products, and for other purposes HR 2565, Office of National Drug Control Reauthorization Act. HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005. HR 810, Stem Cell Research Enhancement Act of 2005. S 109, Pharmaceutical Market Access Act of 2005.

Client expense: Not reported · Firm income: $120,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

FDA, drug approval, generics biologics, importation, clinical trial, drug and safety, PDUFA, conflict of interest HR 2090, Food and Drug Administration Improvement Act of 2005 HR 6257, Access to Life-Saving Medicine Act S 3807, Enhancing Drug Safety and Innovation Act of 2006 S 4016, Access to Life-Saving Medicine Act H.R.700, Pharmaceutical Market Access and Drug Safety Act of 2005, Importation S.109/H.R.328, Pharmaceutical Market Access Act of 2005 S.334, Pharmaceutical Market and Drug Safety Act of 2005 S.930, Food and Drug Administration Safety Act of 2005

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Bioshield reauthorization. S 1873 - Biodefense and Pandemic Vaccine and Drug Development Act of 2005. S 1437 - Bioterror and Pandemic Preparedness Protection Act. HR 5533 - Biodefense and Pandemic Vaccine and Drug Development Act of 2006. S 3807, Enhancing Drug Safety and Innovation Act of 2006. HR 6257, Access to Life-Saving Medicine Act. S 4016, Access to Life-Saving Medicine Act. HR 6143, Ryan White HIV/AIDS Treatment Modernization Act of 2006 Drug Safety, Clinical Trials, drug importation. HR 700/S 334 - Pharmaceutical Market Access and Drug Safety Act of 2005. S 109/HR 328 - Pharmaceutical Market Access Act of 2005. S 930 - Food and Drug Administration Safety Act of 2005.

Client expense: Not reported · Firm income: $120,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

e) S. 109, "Pharmaceutical Market Access Act of 2005". f) S. 334, "Pharmaceutical Market Access & Drug Safety Act of 2005". g) Issues related to clinical trial data bank. h) S. 470, H.R. 3196, "Fair Access to Clinical Trials Act". i) H.R. 6257, "Access to Life-Saving Medicines Act". a) Issues related to Drug Safety, Generic Biologics & Drug Approvals, FDA User Fees. b) S.930, "Food & Drug Administration Act of 2005". c) H.R. 2090, "Food & Drug Administration Improvement Act of 2005". d) H.R. 700, "Pharmaceutical Market Access & Drug Safety Act of 2005" - Importation.

Client expense: $1,231,846 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

S 3274 - Fairness in Asbestos Injury Resolution Act - all matters related to railroad and freight transportation (S 852 and S 109-97) S 3612 - Railroad Antitrust Enforcement Act of 2006 - all matters related to railroad and freight transportation

Client expense: $904,500 · Firm income: Not reported

Government targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Interior, Dept of (DOI), SENATE, Transportation, Dept of (DOT)

HR 5814 - Department of Homeland Security Authorization Act, Title IX and all matters pertaining to railroad and freight transportation S 1516 Passenger Rail Investment and Improvement Act of 2005, all matters pertaining to railroad and freight transportation Senate 2007 Transportation, Treasury, Judiciary and Housing and Urban Development Appropriations, all matters related to railroad and freight transportation HR 1630 Amtrak Reauthorization Act, all matters related to railroad and freight transportation HR 5576 - Fiscal '07 Transportation Appropriations - all matters pertaining to railroad and freight transportation (HR 109-495) HR. 5441 - Fiscal '07 - Homeland Security appropriations - all matters pertaining to railroad and freight transportation (HR 109-476 and S. 109-273)

Client expense: $904,500 · Firm income: Not reported

Government targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Interior, Dept of (DOI), SENATE, Transportation, Dept of (DOT)

S.109, Pharmaceutical Market Access Act of 2005, S.184, Safe IMPORT Act of 2005, Safe Importation of Medical Products and Other Rx Therapies Act of 2005, S.334, Pharmaceutical Market Access and Drug Safety Act of 2005, General discussion regarding drug reimportation, pharmaceutical distribution issues, recent issues with importation and adulterated drugs, ordering and dispensing technology related to hospital pharmacy and out-patient pharmacy activities, drug pricing, prescription drug discount cards, internet drug sales, S.1551, Protecting Free Trade in Pharmaceuticals Act of 2005, H.R.2345, Counterfeit Drug Enforcement Act of 2005, H.R.700, Pharmaceutical Market Access and Drug Safety Act of 2005, FY2005 Appropriations Act for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, S.2668, Reducing Fraudulent and Imitation Drugs Act of 2006, S.2582, Preserve Access to Affordable Generics Act, H.R.5156, Counterfeit Drug Prevention Act of 2006, S.2315, Methamphetamine Awareness and Prevention Act of 2006, H.R.4763, Methamphetamine Education Act, H.R.4829, Reducing Fraudulent and Imitation Drugs Act of 2006 H.R.314, Combat Meth Act of 2005, H.R.328, Pharmaceutical Market Access Act of 2005, S.103, Combat Meth Act of 2005,

Client expense: $320,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues HR 3010, Department of Labor, Health and Human Service, and Education, and Related Agencies Appropriations Act, 2006, access to prescription drugs HR 3971, Social Services Emergency Relief and Recovery Act of 2005, access to prescription drugs HR 5993, Authorized Generics Prohibition, authorized generics S 3695, Authorized Generics Prohibition, authorized generics HR 4157, Better Health Information System Act, health information technology S 2300, Lower PRICED Drug Act, generic drug access, legislation on pediatric exclusivity, citizens petitions HR 6134, Ryan White Care Act, reauthorization S 2339, Ryan White Care Act, reauthorization HR 5975, Prescription Drug Comparative Effectiveness Act, drug prescriptions S 1355, Better Healthcare Through Information Technology Act, health information technology HR 6289, Personalized Health Information Act of 2006, health information technology HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues

Client expense: $7,720,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues HR 870, The PhRMA Research and Manufacturers Accountability (PhRMA) Act, drug safety S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues S 470, The Fair Access to Clinical Trials ("FACT") Act of 2005, drug safety S 930, Food and Drug Administration Safety Act of 2005, drug safety HR 5156, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting S 3834, Online Pharmacy Consumer Protection Act of 2006, drug safety HR 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 4157, Better Health Information System Act, health information technology HR 5975, Prescription Drug Effectiveness Act, drug prescriptions S 2699, Neglected Diseases Elimination Act, promote R&D HR 2090, The Food and Drug Administration Improvement Act of 2005, drug safety HR 3196, The Fair Access to Clinical Trials ("RACT") Act of 2005, drug safety HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation, drug safety

Client expense: $7,720,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, imporation, patent issues S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues S 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To Amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To amend title 35, United States Code, to conform certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 3818, Patent Reform Act of 2006 S 3175, Life-Saving Medicines Export Act of 2006, compulsory licensing S 3834, Online Pharmacy Consumer Protection Act of 2006, prescription drugs S 1903, Generic Prescription Drug Fairness Act of 2005, authorized generics and rebates

Client expense: $7,720,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

Legislation regarding pandemic vaccine production: H.R.3970, Bioterror Pandemic Preparedness Protection Act; H.R.4062, Pandemic Preparedness Response Act; H.R.4603, Pandemic Seasonal Influenza Act of 2005; S.1437, Bioterror Pandemic Preparedness Protection Act;S.1821, Pandemic Preparedness Response Act; S.1873, Biodefense Pandemic Vaccine Drug Development Act of 2005; S.1880, National Biodefense Pandemic Preparedness Act of 2005. Preserve Access to Affordable Drugs Act of 2005; S.873, Medicare Prescription drug Savings and Choice Act of 2005; S.930, Food and Drug Administration Safety Act of 2005. Legislation controlling access to precursor chemicals for meth production and/or combating meth: H.R.1056, Methamphetamine Precursor Control Act of 2005; H.R.13, Clean, Learn, Educate, Abolish, Neutralize, and Undermine Production (CLEAN-UP) of Methamphetamine Act; H.R.1350, Methamphetamine Blister Pack Loophole Elimination Act of 2005; H.R.2335, Meth-Endangered Children Protection Act of 2005; H.R.313, Exile Meth Act; H.R.314, Combat Meth Act of 2005; H.R.3199, Patient Act H.R.1572, Preserving Access to Affordable Drugs Act of 2005; H.R.1626, Medicare Prescription Drug Improvement Act; H.R.1669, Pharmacy Benefit Manager Transparency Act of 2005; H.R.328, Pharmaceutical Market Access Act of 2005; H.R.417, Medical Innovation Prize Act of 2005; H.R.4660, Requiring Emergency Pharmaceutical Access for Individual Relief (REPAIR) Act of 2006; H.R.4663, Authorize the Secretary of HHS to Reimburse States for Expenditures Associated with the Implementation of the Medicare Prescription Drug Benefit for Dual Eligible Individuals; H.R.4665, Amend Title XIX of the Social Security Act to Provide for an Offset from the Medicaid Clawback for State Emergency Prescription Drug Expenditures for Medicare Dual-Eligible Individuals; H.R.4675, Medicare State Reimbursement Act of 2006; H.R.4685, Medicare Prescription Drug Emergency Guarantee Act of 2006; H.R.4715, Amend Title XVIII of the Social Secruity Act to Estend the 2006 Annual Coordinated Election Period for Medicare Prescription Drug Plans through August 15, 2006; H.R.4719, Patients Before Profits Act of 2006; H.R.4721, Require Secretary of HHS To Provide Federal Medicaid for State Costs Associated with Ensuring Access to Prescription Drug Benefits to Part D Eligible Individuals; H.R.700, Pharmaceutical Market Access and Drug Safety Act of 2005; H.R.752, Medicare Prescription Drug Savings and Choice Act of 2005; H.R.870, Pharmaceutical research and Manufacturers Accountability Act of 2005, PhRMA Act of 2005; S.109, Pharmaceutical Market Access Act of 2005; S.1128, Pharmaceutical Advertising and Prudent Purchasing Act; S.334, Pharmaceutical Market Access and Drug Safety Act of 2005; S.354, HEALTH Act of 2005, Health Efficient, Accessible, Low-Cost, timely Healthcare Act of 2005; S.764, Preserve Access to Affordable Drugs Act of 2005; S.873, Medicare Prescription drug Savings and Choice Act of 2005; S.930, Food and Drug Administration Safety Act of 2005. Methamphetamine Precursor Control Act of 2005; H.R.13, Clean, Learn, Educate, Abolish, Neutralize, and Undermine Production (CLEAN-UP) of Methamphetamine Act; H.R.1350, Methamphetamine Blister Pack Loophole Elimination Act of 2005; H.R.152, Preserving Access to Affordable Drugs Act of 2005; H.R.1572, Preserving Access to Affordable Drugs Act of 2005; H.R.1626, Medicare Prescription Drug Improvement Act; H.R.1669, Pharmacy Benefit Manager Transparency Act of 2005; H.R.2335, Meth-Endangered Children Protection Act of 2005; H.R.313, Exile Meth Act; H.R.314, Combat Meth Act of 2005; H.R.3199, Patient Act Reauthorization; H.R.328, Pharmaceutical Market Access Act of 2005; H.R.3324, Arrest Methamphetamine Act of 2005; H.R.3889, The Methamphetamine Elimination Act; H.R.3970, Bioterror Pandemic Preparedness Protection Act; H.R.4062, Pandemic Preparedness Response Act; H.R.4603, Pandemic Seasonal Influenza Act of 2005; H.R.4660, Requiring Emergency Pharmaceutical Access for Individual Relief (REPAIR) Act of 2006; H.R.4663, Authorize the Secretary of HHS to Reimburse States for Expenditures Associated with the Implementation of the Medicare Prescription Drug Benefit for Dual Eligible Individuals; H.R.4665, Amend Title XIX of the Social Security Act to Provide for an Offset from the Medicaid Clawback for State Emergency Prescription Drug Expenditures for Medicare Dual-Eligible Individuals; H.R.4675, Medicare State Reimbursement Act of 2006; H.R.4685, Medicare Prescription Drug Emergency Guarantee Act of 2006; H.R.4715, Amend Title XVIII of the Social Secruity Act to Estend the 2006 Annual Coordinated Election Period for Medicare Prescription Drug Plans through August 15, 2006; H.R.4719, Patients Before Profits Act of 2006; H.R.4721, Require Secretary of HHS To Provide Federal Medicaid for State Costs Associated with Ensuring Access to Prescription Drug Benefits to Part D Eligible Individuals; H.R.700, Pharmaceutical Market Access and Drug Safety Act of 2005; H.R.417, Medical Innovation Prize Act of 2005; H.R.752, Medicare Prescription Drug Savings and Choice Act of 2005; H.R.798, Methamphetamine Remediation Act of 2005; H.R.870, Pharmaceutical research and Manufacturers Accountability Act of 2005, PhRMA Act of 2005; S.103, Combat Meth Act of 2005; S.109, Pharmaceutical Market Access Act of 2005; S.1128, Pharmaceutical Advertising and Prudent Purchasing Act; S.1361, A bill to amend the Controlled Substances Act to treat drug offenses involving crystal meth similarly to drug offenses involving crack cocaine; S.1437, Bioterror Pandemic Preparedness Protection Act; S.1821, Pandemic Preparedness Response Act; S.1873, Biodefense Pandemic Vaccine Drug Development Act of 2005; S.1880, National Biodefense Pandemic Preparedness Act of 2005; S.334, Pharmaceutical Market Access and Drug Safety Act of 2005; S.354, HEALTH Act of 2005, Health Efficient, Accessible, Low-Cost, timely Healthcare Act of 2005; S.764, H.CON.RES.75, Expressing the sense of the congress that the illegal importation of prescription drugs severely undermines the regulatory protections afforded to the United States consumers, and for other purposes; H.R.1056,

Client expense: $820,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Access to local Pharmacies, reimbursement rates - HR 1539, HR 1808, S 778, S 809/HR 1652, S 2264, S 109/HR 328, S 103/HR 314, HR 5762/S 2480

Client expense: Not reported · Firm income: $20,000

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), SENATE, U.S. Customs & Border Protection, U.S. Trade Representative (USTR)

H.R. 2345 Counterfeit Drug Enforcement Act of 2005 H.R. 4829 Reducing Fruadulant and Imitation Drug Act of 2005: S. 2300 Lower PRICED Drug Act. Meetings with Members of Congress regarding generic biologics and Food and Drug Administration regulatory activity of interest to the Registrant. Various bills regarding the importation of prescription drugs including: H.R. 328, S. 109, H.R. 700, S. 334. H.R. 753, and S. 184. H.R. 5993, S. 3695: legislation to prohibit the marketing of authorized generic drugs.

Client expense: $440,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Pharmaceutical issues, SCR 18; Pharmaceutical market access, S. 109, H.R. 328; Pharmaceutical importation, S. 184.

Client expense: Not reported · Firm income: $100,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S 3807, Enhancing Drug Safety and Innovation Act of 2006 HR 6257, Access to Life-Saving Medicine Act Drug Approval Issues, Drug Safety Issues, FDA Issues Clinical Trials Conflict of Interest, Follow-on Biologics, PDUFA IV Issues relating to generics, biotechnology, and drug reimportation H.R.700/S334 Pharmaceutical Market Access and Drug and Safety Act of 2005/S334 H.R.328/S109 Pharmaceutical Market Access Act of 2005 S930 Food and Drug Administration Safety Act of 2005

Client expense: Not reported · Firm income: $100,000

Government targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S.109, Pharmaceutical Market Access Act of 2005, S.184, Safe IMPORT Act of 2005, Safe Importation of Medical Products and Other Rx Therapies Act of 2005, S.334, Pharmaceutical Market Access and Drug Safety Act of 2005, General discussion regarding drug reimportation, pharmaceutical distribution issues, recent issues with importation and adulterated drugs, ordering and dispensing technology related to hospital pharmacy and out-patient pharmacy activities, drug pricing, prescription drug discount cards, internet drug sales, S.1551, Protecting Free Trade in Pharmaceuticals Act of 2005, H.R.2345, Counterfeit Drug Enforcement Act of 2005, H.R.700, Pharmaceutical Market Access and Drug Safety Act of 2005, FY2005 Appropriations Act for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, S.2668, Reducing Fraudulent and Imitation Drugs Act of 2006, S.2582, Preserve Access to Affordable Generics Act, H.R.5156, Counterfeit Drug Prevention Act of 2006, S.2315, Methamphetamine Awareness and Prevention Act of 2006, H.R.4763, Methamphetamine Education Act, H.R.4829, Reducing Fraudulent and Imitation Drugs Act of 2006 H.R.314, Combat Meth Act of 2005, H.R.328, Pharmaceutical Market Access Act of 2005, S.103, Combat Meth Act of 2005,

Client expense: Not reported · Firm income: $40,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 5 - Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2005; H.R. 4544 - 340B Program Revision and Expansion Act of 2005; S. 1840/H.R. 3547 Safety Net Inpatient Drug Affordability Act of 2005; S.4/S. 1503 - Healthy America Act of 2005; S. 1420/H.R. 3423 - Medical Device User Fee Stabilization Act of 2005; H.R. 2234 - 21st Century Health Information Act of 2005; S. 3685/H.R. 5993 - To amend the Federal Food, Drug and Comestic Act to prohinit the marketing of authorized generic drug; S. 1903 - Generic Presription Drug Fairness Act of 2005; S. 3582 - Preserve Access to Affordable Generic Act of 2006; S. 4016/H.R. 6257 - Access to Life-Saving Medicine Act of 2006; S. 306/H.R. 1227 - Genetic Information Non-Discrimination act of 2005 S. 334/S. 109 - Pharmacetuical Market Access and Drug Safety Act of 2005; S. 1418 - Wired for Health Care Quality Act of 2005; S. 1233 - Information Technology for Health Care Quality Act of 2005

Client expense: $1,040,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

H.R. 328 and S. 109 - Pharmaceutical Market Access Act of 2005 - all provisions relating to re-importation of prescription drugs; H.R. 700 & S. 334 - Pharmaceutical Market Access and Drug Safety Act of 2005 - same as above

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 22 Postal Accountability and Enhancement Act HR 184 Controlled Substances Export Reform Act of 2005 HR 218 Health Care Tax Deduction Act of 2005 HR 328 Pharmaceutical Market Access Act of 2005 HR 700 Pharmaceutical Market Access and Drug Safety Act of 2005 HR 753 Safe Importation of Medical Products and Other Rx Therapies Act of 2005 HR 747 National Health Information Incentive Act of 2005 HR 1132 National All Schedules Prescription Electronic Reporting Act of 2005 HR 1223 Information Technology for Health Care Quality Act HR 4832 Electronic Health Information Technology Act of 2006 HR 4157 Health Information Technology Promotion Act of 2005 HR 5166 Independent Pharmacy Protection Act of 2006 HR 5182 Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2006 HR 1626 Medicare Prescription Drug Improvement Act HR 1669 Pharmacy Benefit Manager Transparency Act of 2005 HR 1671 Community Pharmacy Fairness Act of 2005 HR 1710 Internet Police Protection Act of 2005' HR 1808 Safe Online Drug Act of 2005 HR 2234 21st Century Health Information Act of 2005 HR 2664 Biennial Budgeting and Appropriations Act of 2005 HR 2774 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2006 HR 5384 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2007 S 4 Healthy America Act of 2005 S 16 Affordable Health Care Act S 109 Pharmaceutical Market Access Act of 2005 S 184 Safe Importation of Medical Products and Other Rx Therapies Act of 2005 S 334 Pharmaceutical Market Access and Drug Safety Act of 2005 S 518 National All Schedules Prescription Electronic Reporting Act of 2005 S 662 Postal Accountability and Enhancement Act S 975 Project BiosSheild II Act of 2005 S 1223 Information Technology for Health Care Quality Act S 1227 Health Information Technology Act of 2005 S 1262 Health Technology to Enhance Quality Act of 2005 S 1418 Wired for Health Care Quality Act S 2072 Medicare Early Access Act of 2005 S 2090 Food and Drug Administration Act of 2005 S 2551 Prompt Payment of Health Benefits Claims Act of 2006 S 2563 Pharmacist Access and Recognition in Medicare (PhARM) Act of 2006 S. 2665 Pharmacy Access Improvement (PhAIm) Act of 2006 See next page

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 22 Postal Accountability and Enhancement Act HR 184 Controlled Substances Export Reform Act of 2005 HR 218 Health Care Tax Deduction Act of 2005 HR 328 Pharmaceutical Market Access Act of 2005 HR 700 Pharmaceutical Market Access and Drug Safety Act of 2005 HR 753 Safe Importation of Medical Products and Other Rx Therapies Act of 2005 HR 747 National Health Information Incentive Act of 2005 HR 1132 National All Schedules Prescription Electronic Reporting Act of 2005 HR 1223 Information Technology for Health Care Quality Act HR 4832 Electronic Health Information Technology Act of 2006 HR 4157 Health Information Technology Promotion Act of 2005 HR 5166 Independent Pharmacy Protection Act of 2006 HR 5182 Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2006 HR 1626 Medicare Prescription Drug Improvement Act HR 1669 Pharmacy Benefit Manager Transparency Act of 2005 HR 1671 Community Pharmacy Fairness Act of 2005 HR 1710 Internet Police Protection Act of 2005' HR 1808 Safe Online Drug Act of 2005 HR 2234 21st Century Health Information Act of 2005 HR 2664 Biennial Budgeting and Appropriations Act of 2005 HR 2774 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2006 HR 5384 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2007 S 4 Healthy America Act of 2005 S 16 Affordable Health Care Act S 109 Pharmaceutical Market Access Act of 2005 S 184 Safe Importation of Medical Products and Other Rx Therapies Act of 2005 S 334 Pharmaceutical Market Access and Drug Safety Act of 2005 S 518 National All Schedules Prescription Electronic Reporting Act of 2005 S 662 Postal Accountability and Enhancement Act S 975 Project BiosSheild II Act of 2005 S 1223 Information Technology for Health Care Quality Act S 1227 Health Information Technology Act of 2005 S 1262 Health Technology to Enhance Quality Act of 2005 S 1418 Wired for Health Care Quality Act S 2072 Medicare Early Access Act of 2005 S 2090 Food and Drug Administration Act of 2005 S 2551 Prompt Payment of Health Benefits Claims Act of 2006 S 2563 Pharmacist Access and Recognition in Medicare (PhARM) Act of 2006 S. 2665 Pharmacy Access Improvement (PhAIm) Act of 2006 See next page

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 22 Postal Accountability and Enhancement Act HR 184 Controlled Substances Export Reform Act of 2005 HR 218 Health Care Tax Deduction Act of 2005 HR 328 Pharmaceutical Market Access Act of 2005 HR 700 Pharmaceutical Market Access and Drug Safety Act of 2005 HR 753 Safe Importation of Medical Products and Other Rx Therapies Act of 2005 HR 747 National Health Information Incentive Act of 2005 HR 1132 National All Schedules Prescription Electronic Reporting Act of 2005 HR 1223 Information Technology for Health Care Quality Act HR 4832 Electronic Health Information Technology Act of 2006 HR 4157 Health Information Technology Promotion Act of 2005 HR 5166 Independent Pharmacy Protection Act of 2006 HR 5182 Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2006 HR 1626 Medicare Prescription Drug Improvement Act HR 1669 Pharmacy Benefit Manager Transparency Act of 2005 HR 1671 Community Pharmacy Fairness Act of 2005 HR 1710 Internet Police Protection Act of 2005' HR 1808 Safe Online Drug Act of 2005 HR 2234 21st Century Health Information Act of 2005 HR 2664 Biennial Budgeting and Appropriations Act of 2005 HR 2774 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2006 HR 5384 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2007 S 4 Healthy America Act of 2005 S 16 Affordable Health Care Act S 109 Pharmaceutical Market Access Act of 2005 S 184 Safe Importation of Medical Products and Other Rx Therapies Act of 2005 S 334 Pharmaceutical Market Access and Drug Safety Act of 2005 S 518 National All Schedules Prescription Electronic Reporting Act of 2005 S 662 Postal Accountability and Enhancement Act S 975 Project BiosSheild II Act of 2005 S 1223 Information Technology for Health Care Quality Act S 1227 Health Information Technology Act of 2005 S 1262 Health Technology to Enhance Quality Act of 2005 S 1418 Wired for Health Care Quality Act S 2072 Medicare Early Access Act of 2005 S 2090 Food and Drug Administration Act of 2005 S 2551 Prompt Payment of Health Benefits Claims Act of 2006 S 2563 Pharmacist Access and Recognition in Medicare (PhARM) Act of 2006 S. 2665 Pharmacy Access Improvement (PhAIm) Act of 2006 See next page

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues pertaining to the treatment of asthma HR.328, Pharmaceutical Market Access Act of 2005 S.109, Pharmaceutical Market Access Act of 2005

Client expense: Not reported · Firm income: $80,000

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

EPA Environ. Policy Res., Fossil Energy Res. Dev., Bioreneable Research, Egg Emissions Mitigation Ag Approp: HR5384, HR109-463, SR109-266; Energy & Water: HR5427, HR109-474, SR109-274; Int. & Environ.: HR5386, H109-465, S109-275; H.J. Res. 20

Client expense: $51,927 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Energy, Dept of, Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Agency for International Development (USAID)

Science & Tech funding; computer security, reducing wind-induced damages from storms. Ag: HR5384, H109-463, S109-266; Sc/State/Jus/Comm: HR5672, H109-520, S109-280; Energy & Water:HR5427, H109-474, S109-274; Homeland Security: HR5441, H109-476, S109-273; H.J. Res. 20

Client expense: $51,927 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Energy, Dept of, Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Agency for International Development (USAID)

Fair Access to Clinical Trials Act (S470/HR3196); FDA Improvement Act (S930/HR2090); Wired for Health Care Quality Act (S1418); Pharmaceutical Market Access and Drug Safety Act (S109/S334/HR328/HR700); Labor-HHS Appropriations; AHRQ Comparative Effectiveness Research (HR 5975); Reauthorization of PDUFA; Health Information Technology (HR 4157/S 1418) FDA reform regarding oversight of drug safety.

Client expense: $50,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S 366 - 'Healthy Mothers & Healthy Babies Access to Care Act of 2005' All provisions pertaining to the bill. S 367 - 'Pregnancy & Trauma Care Access Protection Act of 2005' All provisions pertaining to the bill. S 406 - 'H.E.A.L.T.H. (Help Efficient, Accessible, Low-Cost, Timely Health Care) Act' All provisions pertaining to the bill. S544 - 'Patient Safety and Quality Improvement Act' All provisions pertaining to the bill. S 723 - 'SIMPLE Cafeteria Plan Act' All provisions pertaining to the bill. S 978 - 'Health Care Tax Relief for the Uninsured Act of 2005 ' All provisions pertaining to the bill. S 1015 - 'Health Care Choice Act' All provisions pertaining to the bill. S 1244 - 'Long-Term Care & Retirement Security Act of 2005' All provisions pertaining to the bill. S 1418 - 'Wired for Health Care Quality Act' All provisions pertaining to the bill. S 1569 - 'State Long Term Care Partnership Act of 2005' All provisions pertaining to the bill. S 1602 - 'Long-Term Care Choices Act of 2005' All provisions pertaining to the bill. S 1659 - 'State Long-Term Care Partnership Act of 2005' All provisions pertaining to the bill. S 1932 - 'Deficit Reduction Act of 2005' All provisions pertaining to long-term care and Medicaid reform. S 1955 - 'Health Insurance Marketplace Modernization & Affordability Act of 2005' All provisions pertaining to small group reform. S 2300 - 'Lower PRICED Drugs Act' All provisions pertaining to the bill. HR 525/994 - 'Small Business Health Fairness Act': all provisions related to the allowance of federal, civilian and military retirees to pay health insurance premiums on a pre-tax basis, and allowing tax deductions for TRICARE supplemental premiums. HR 534 - 'Help Efficient, Accessible, Low-Cost, Timely Healthcare ("HEALTH") Act All provisions related to the bill HR 976 - 'Long-Term Care Act of 2005' All provisions related to the bill. HR 1227 - 'Genetic Information Non-Discrimination Act' All provisions related to the bill. HR 1872 - 'Health Coverage for the Uninsured Act' All provisions related to the bill. HR 2071 - 'Family Care Act' All provisions related to the bill. HR 2355 - 'Health Care Choice Act' All provisions related to the bill. HR 2682 - 'Long Term Care and Retirement Security Act' All provisions related to the bill. HR 2830 - 'Pension Protection Act' All provisions related to the bill. HR 3204 - 'State High Risk Pool Funding Extension Act of 2005' All provisions related to the bill. HR 3511 - 'Medicaid State Long Term Care Partnership Program Act of 2005' All provisions related to the bill. HR 4157 - 'Health Information Technology Promotion Act' All provisions related to the bill. HR 4241 - 'Budget Reconciliation' All provisions related to health care or similar budget amounts. HR 4511 - 'Flex Saving Accounts Act of 2005' All provisions related to the bill. HR 5262 - 'Tax Free Health Savings Act of 2006' All provisions pertaining to the bill. HR 5384 - 'Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2007' All provisions related to additional emergency funding to aid FDA backlog. S 4 - 'Healthy America Act of 2005' All provisions pertaining to the bill. S 5 - 'Class Action Fairness' All provisions pertaining to the bill. S 109 - 'Pharmaceutical Market Access Act' All provisions pertaining to the bill. S 160 - 'S.A.V.E. Act' All provisions pertaining to the bill. S 184 - 'Safe Import Act' All provisions pertaining to the bill. S 288 - 'State High Rick Poll Funding Extension Act' All provisions pertaining to the bill. S 306 - 'Genetic Information Nondiscrimination Act' All provisions pertaining to the bill. S 309 - which proposes to amend the IRS Code of 1986 to provide for the disposition of unused health benefits in cafeteria and flexible spending arrangements. All provisions pertaining to the bill. S 354 - 'The Long Term Care and Retirement Security Act of 2003' All provisions pertaining to the bill. HR 218 - 'Health Care Tax Deduction Act' All provisions related to the bill.

Client expense: $250,000 · Firm income: Not reported

Government targets: Administration on Aging, Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Personnel Management (OPM), SENATE, Treasury, Dept of, White House Office

Drug safety and importation issues, Clinical trials. Generics Biologics HR 328, Pharmaceuticals Market Access Act of 2005. HR 2090, Food and Drug Administration Improvement Act of 2005. S 2766, National Defense Authorization Act for Fiscal Year 2007; Drug pricing. S 3807, Enhancing Drug Safety and Innovation Act of 2006. HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005. S 109, Pharmaceutical Market Access Act of 2005. S 334, Pharmaceutical Market Access and Drug Safety Act of 2005. S 930, Food and Drug Administration Safety Act of 2005.

Client expense: Not reported · Firm income: $100,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

1. S. 334, HR 700, S. 1551, S. 109, HR 2744-Specifically, provisions relating to the importation of prescription drugs. 2. S. 930-A bill to amend the Food and Drug Administration Safety Act, with respect to drug safety.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 109- Pharmaceutical Market Access Act of 2005; S. 184-Safe Import Act of 2005; H.R. 700, S. 334-Pharmaceutical Market Access and Drug Safety Act of 2005; and S. 930 Food & Drug Administration Safety Act of 2005.

Client expense: Not reported · Firm income: $120,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

CJS Report S. 109-280, Additional Franchise Requirements

Client expense: Not reported · Firm income: $120,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Drug importation, drug safety issues, clinical trials Conflict of Interest, PDUFA, Drug pricing S 2766, national Defense Authorization Act for Fiscal Year 2007; drug pricing. HR 2090, Food and Drug Administration Improvement Act of 2005 HR 328, Pharmaceutical Market Access Act of 2005. S 3807, Enhancing Drug Safety and Innovation Act of 2006 S 4016, Access to Life-Saving Medicine Act HR 6257, Access to Life-Saving Medicine Act HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, Importation. S 109, Pharmaceutical Market Access Act of 2005. S 334 Pharmaceutical Market Access and Drug Safety Act of 2005. S 930, Food and Drug Administration Safety Act of 2005.

Client expense: Not reported · Firm income: $180,000

Government targets: Centers For Disease Control & Prevention (CDC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of the Vice President of the United States, SENATE

HR. 5009, Ryan White CARE Act Amendments of 2006 Issues relating to pharmaceutical compounding Issues relating to Medicare Part D Issues relating to CFC Supply and essentiality S. 3807, Enhancing Drug Safety and Innovation Act of 2006 S. 4016 and HR. 6257, Access to Life Saving Medicine Act S. 3695, relating to the prohibition of authorized generic drugs HR. 328, Pharmaceutical Market Access Act of 2005 S. 109, Pharmaceutical Market Access Act of 2005 HR. 6143, The Ryan White HIV/AIDS Treatment Modernization Act S. 2339, Ryan White CARE Act Amendments of 2006

Client expense: $713,336 · Firm income: Not reported

Government targets: Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS)

S 222, S 873, S 581, S 345, S 18, S 877, S 1074, S 747, S 334, S 239, S 109, S 184, S 3, S 2493, S 2328, S 2307, S 1307, S 991 HR 918, HR 752, HR 2664, HR 2774, HR 2948, Hr 328, Hr 2427, H Con Res 95, HR 2830, HR 3045

Client expense: Not reported · Firm income: $33,750

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S 222, S 873, S 581, S 345, S 18, S 877, S 1074, S 747, S 334, S 239, S 109, S 184, S 3, S 2493, S 2328, S 2307, S 1307, S 991 HR 918, HR 752, HR 2664, HR 2774, HR 2948, Hr 328, Hr 2427, H Con Res 95, HR 2830, HR 3045

Client expense: Not reported · Firm income: $33,750

Government targets: HOUSE OF REPRESENTATIVES, SENATE